A durable patient asset
The organized longitudinal record remains useful as providers, technologies, and AI models change. Sources, identity, dates, corrections, and context stay centered on the patient.
PBRx, LLC · Company overview
PBRx is developing patient-controlled infrastructure that organizes fragmented health information into durable, evidence-linked longitudinal intelligence—designed to help people understand their history and prepare for better healthcare conversations.
PBRx is a privately held company in controlled prototype development. This page contains general company information only and is not an offer or solicitation of securities.
The value pathway
Why PBRx
Healthcare information is still divided across institutions, portals, documents, devices, and years. PBRx is designed around the patient as the enduring point of continuity.
The organized longitudinal record remains useful as providers, technologies, and AI models change. Sources, identity, dates, corrections, and context stay centered on the patient.
PBRx is designed to preserve provenance, distinguish facts from interpretation, expose uncertainty, and make important summaries traceable to their source.
The same connected foundation can support record organization, appointment preparation, care-gap review, longitudinal reports, caregiver coordination, and future authorized integrations.
AI supports organization and understanding while patients retain control and qualified healthcare professionals retain clinical authority.
Designed to be different
PBRx is designed as an intelligence layer centered on the individual, with a durable record that can connect information across organizational boundaries while keeping evidence visible.
Institutions see episodes. PBRx is designed to preserve the health story across providers, care settings, devices, and time.
AI services can evolve without surrendering the patient’s organized evidence, provenance, permissions, or longitudinal structure.
Health Intelligence Cards and reports are designed to expose sources, dates, confidence, conflicts, and unresolved gaps.
Patient, family, proxy, caregiver, and professional roles require purpose-specific authority rather than broad, invisible access.
A result can be compared with the individual’s recent, annual, and lifetime history instead of being treated as an isolated snapshot.
PBRx is designed to organize and prepare. It does not replace diagnosis, treatment decisions, emergency care, or qualified professional authority.
Intellectual property strategy
Patent pendingPBRx is pursuing patent protection for aspects of its technology and workflows. The company’s intellectual-property strategy is intended to support long-term product development while preserving the distinctive architecture, methods, software, brand, and operational knowledge created around the PBRx platform.
“Patent pending” means that one or more patent applications have been filed. It does not mean a patent has been granted and does not guarantee issuance, claim scope, validity, enforceability, freedom to operate, or commercial success.
Potentially protectable aspects of the PBRx platform may include elements of longitudinal health-information organization, evidence-linked intelligence, personal-context workflows, and related system methods, subject to the actual applications and patent examination.
PBRx-developed software, data structures, permission logic, report designs, safety gates, validation methods, and operating workflows contribute to the company’s implementation advantage.
PBRx™, Longitudinal Health Intelligence™, platform content, interfaces, documentation, and original visual materials form part of the company’s broader brand and copyright portfolio, subject to applicable rights and registrations.
Healthcare-domain experience, integration knowledge, security practices, evaluation methods, partner relationships, and the discipline required to operate responsibly are important assets beyond formal patent rights.
Trust as infrastructure
PBRx is being developed with privacy, security, source traceability, bounded AI use, and accountable human review as platform requirements—not late-stage additions.
Review PBRx’s HIPAA and BAA approachPBRx uses eligible OpenAI API services under an executed BAA and approved data-retention controls for authorized workflows involving protected health information.
PBRx uses covered Proton services under an executed BAA, with clear boundaries for email configuration and protected-information handling.
Contracts must operate alongside access controls, risk management, security testing, incident response, vendor oversight, training, and correct system configuration.
Future development priorities
The company’s development strategy remains subject to validation, applicable law, security readiness, partner requirements, and the needs of PBRx.
Advance the Health Vault, longitudinal intelligence, reporting, permissions, delegated access, and patient-facing experiences.
Expand independent testing, policy operations, monitoring, audit readiness, vendor governance, and production controls.
Support carefully governed pilots that assess comprehension, preparation, continuity, safety, and real-world usefulness.
Develop authorized connections with health-data sources, devices, care organizations, research partners, and aligned distribution channels.
Potential paths to scale
These are potential strategic pathways, not current revenue forecasts, financing terms, or commitments. Each would require validation, appropriate agreements, and responsible operating controls.
Tools that help people build, understand, and carry their health story across time.
Permissioned coordination for people helping manage care, records, and appointments.
Purpose-built deployment pathways for populations with complex, distributed health histories.
Governed pilots, authorized integrations, research, and patient-engagement initiatives.
Current stage
PBRx is operating as a controlled functional prototype in closed beta. The public website does not accept or store personal health information. Product descriptions remain subject to validation, security hardening, regulatory analysis, partner requirements, and responsible release controls.
Explore the foundation
PBRx’s public materials separate current status from future capabilities and make key safety and operating boundaries visible.
Company information
Explore the company’s mission, trust framework, medical and AI standards, and controlled-beta development. General partnership and company inquiries are delivered privately to the PBRx team through the contact form. PBRx does not accept investment commitments, reservations, or securities purchase requests through this website.
This page is provided solely for general company information. PBRx, LLC is not offering or selling securities through this website, and nothing on this page constitutes an offer to sell, a solicitation of an offer to buy, investment advice, or a recommendation. No investment opportunity is currently available through this page.
The website does not collect indications of investment interest, investor eligibility information, reservations, commitments, or securities purchase requests. If PBRx ever conducts a financing, any offer would be made separately and only through appropriate offering materials, risk disclosures, eligibility and verification procedures, and compliance with applicable federal and state securities laws. Statements about plans, product capabilities, markets, or future development are forward-looking, involve risks and uncertainties, and are not guarantees of performance or results.